HIGH

Sterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012%), 0.5 fl oz (15 mL) bottles; a) Industrial Eye Relief, Distributed by: Cintas Corp., Mason, OH 45040, UPC 130209; b)...

Lack of Assurance of Sterility

Quick Facts at a Glance

Recall Date
March 3, 2026
Hazard Level
HIGH
Brands
GNP EYE DROPS REDNESS AND DRY EYE RELIEF, LEADER EYE DROPS REDNESS RELIEF, FOSTER AND THRIVE REDNESS RELIEF EYE DROPS...
Geographic Scope
1 states

Hazard Information

Lack of Assurance of Sterility

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact K.C. Pharmaceuticals, Inc or your healthcare provider for guidance. Notification method: E-Mail

Get instant alerts for GNP EYE DROPS REDNESS AND DRY EYE RELIEF recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Sterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012%), 0.5 fl oz (15 mL) bottles; a) Industrial Eye Relief, Distributed by: Cintas Corp., Mason, OH 45040, UPC 130209; b) Good Neighbor Pharmacy Eye Drops, Redness & Dry Eye Relief, Distributed By AmerisourceBergen, Conshohocken, PA 19428, NDC 46122-606-05; c) Colirio Ojo De Aguila Eye Drops, Distributed by: Grandall Distributing Co., Inc., Glendale, CA 91204-2707, UPC 3 48201 01615 5; d) Colirio OFTAL-MYCIN, Distributed by: Grandall Distributing Co., Inc., Glendale, CA 91204-2707, UPC 3 48201 01613 1; e) LEADER Redness Relief, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, www.myleader.com, NDC 70000-0010-1; f) Equaline, sterile redness relief, DISTRIBUTED BY UNFI, PROVIDENCE, RI 02908, UPC 0 41163 46151 2; g) Walgreens, Redness Relief Eye Drops, DISTRIBUTED BY: WALGREEN CO., DEERFIELD, IL 60015, UPC 3 11917 17741 0; h) Foster & Thrive, Redness Relief Eye Drops, Sterile, Distributed by: McKesson Corp., via SSSL, Memphis, TN 38141, www.fosterandthrive.com, NDC 70677-1161-1; i) LUBRICANT EYE DROPS, Redness Relief, DISTRIBUTEDBY: RITE AID, 30 HUNTER LANE, CAMP HILL, PA 17011, NDC 11822-6453-4; j) Discount drug mart, Eye Drops Redness Relief, Distributed by: Discount Drug Mart, Medina, OH 44256, UPC 0 93351 03411 4. Generic: GLYCERIN, NAPHAZOLINE HCL, GLYCERIN, NAPHAZOLINE HYDROCHLORIDE; Brand: GNP EYE DROPS REDNESS AND DRY EYE RELIEF, LEADER EYE DROPS REDNESS RELIEF, FOSTER AND THRIVE REDNESS RELIEF EYE DROPS. Reason: Lack of Assurance of Sterility. Classification: Class II. Quantity: 315,144 bottles. Distribution: Nationwide in the US

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot: a) RL24D01
Exp.: 04/30/26
RL24F01
RL24F02
Exp.:06/30/26
+15 more
UPC Codes
46122-606
70000-0010
70677-1161
+5 more
Affected States
ALL
Report Date
April 8, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
CRITICAL

Massive Eye Drop Recall Hits CVS, Walgreens, Kroger — 8 Products Never Tested for Sterility (2026)

Millions of eye drop bottles sold at CVS, Walgreens, Kroger, and other major pharmacies may not be sterile. K.C. Pharmaceuticals of Pomona, California never verified that eight of its over-the-counter eye drop products met sterility standards, the FDA warned. A nearly identical manufacturing failure in 2023 left patients blind, cost others their eyes, and killed at least three people. Consumers should stop using the products and return them for a full refund.

CVS Health
Nonsterile eye
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

MAGNESIUM SULFATE
Product mix
Read more
Health & Personal Care
HIGH

Teva Octreotide Acetate Injectable Suspension Recall 21,930 Cartons Over Sterility Risk (2026)

Teva Pharmaceuticals recalled 21,930 cartons of Octreotide Acetate for Injectable Suspension distributed nationwide in the United States. The recall stems from lack of assurance of sterility identified during an FDA inspection at the contract manufacturer. Healthcare providers and patients should stop using this product immediately and contact Teva or a physician for guidance.

OCTREOTIDE ACETATE
Lack of
Read more